Early research (Phase 1)Study completedNCT00474669What this trial is testingA Phase I Study of Intraperitoneal Hyperthermic DocetaxelWho this might be right forOvarian Carcinoma University of Louisville 30
Not applicableEnded earlyNCT02930460What this trial is testingProspective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.Who this might be right forObstructive Sleep Apnea ResMed 30
Testing effectiveness (Phase 2)Study completedNCT03895970What this trial is testingLenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsWho this might be right forLiver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more Peking Union Medical College Hospital 32
Not applicableLooking for participantsNCT06371274What this trial is testingA Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.Who this might be right forTriple-negative Breast Cancer First Affiliated Hospital of Zhejiang University 29
Testing effectiveness (Phase 2)Study completedNCT04835896What this trial is testingStudy of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649980What this trial is testingBecotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase IIWho this might be right forBiliary Tract Cancer (BTC)EGFR-positive Advanced Biliary Tract Carcinoma HuiKai Li 30
Early research (Phase 1)UnknownNCT05675462What this trial is testingOncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Fudan University 25
Testing effectiveness (Phase 2)UnknownNCT04572542What this trial is testingCamrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerWho this might be right forLocally Advanced or Metastatic Gastric Adenocarcinoma The First Affiliated Hospital of Xiamen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07559760What this trial is testingNew Second-Line Combo Therapy for MSS Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer The First Hospital of Jilin University 30
Testing effectiveness (Phase 2)Study completedNCT00305786What this trial is testingGemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Miami 30
Testing effectiveness (Phase 2)Study completedNCT02716766What this trial is testingStudy of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)Who this might be right forCarcinoma, HepatocellularSecondary The University of Hong Kong 46
Testing effectiveness (Phase 2)Study completedNCT01298570What this trial is testingRegorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerWho this might be right forColorectal Cancer Metastatic UNC Lineberger Comprehensive Cancer Center 181
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Testing effectiveness (Phase 2)Study completedNCT01750281What this trial is testingAssess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.Who this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV AstraZeneca 212
Testing effectiveness (Phase 2)UnknownNCT03403101What this trial is testingThe Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerWho this might be right forCarcinoma, Pancreatic Ductal Fudan University 65
Testing effectiveness (Phase 2)UnknownNCT03204734What this trial is testingCapecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerWho this might be right forBreast Cancer Zhejiang Cancer Hospital 132
Testing effectiveness (Phase 2)Study completedNCT05001971What this trial is testingAnlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based ChemotherapyWho this might be right forSmall Cell Lung Cancer Hunan Cancer Hospital 65
Large-scale testing (Phase 3)Study completedNCT02785939What this trial is testingLung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerWho this might be right forCCND1 Gene AmplificationCCND2 Gene AmplificationCCND3 Gene Amplification+3 more SWOG Cancer Research Network 53
Not applicableLooking for participantsNCT06751953What this trial is testingNeoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line TreatmentWho this might be right forColorectal Cancer (CRC) The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)UnknownNCT02596256What this trial is testingApatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)Who this might be right forGastric Cancer Chinese PLA General Hospital 80